Efficacy of Dexamethasone in Treatment of Meconium Aspiration Syndrome
Status:
Completed
Trial end date:
2021-06-30
Target enrollment:
Participant gender:
Summary
Objective: To determine efficacy of dexamethasone in treatment of meconium aspiration
syndrome.
Study design: Randomized control trial. Place and duration: Services hospital, Neonatal unit,
Lahore. During time span of 1st January to 30th June 2021.
Material and methods Total 100 neonates were randomly divided in two groups. Group A (n=50)
was treated with dexamethasone (Cases) and Group B (n=50) served as control. Dexamethasone
was given in dose of 0.2mg/kg, 12 hourly for 7 days after confirmation of diagnosis. Infants
present in clinical trial were evaluated by ventilation duration (invasive and non-invasive),
oxygen therapy and hospital stay.